Javascript must be enabled to continue!
Apomorphine hydrochloride: a clinical review with retrospective analysis of use in 1126 dogs treated in emergency practice
View through CrossRef
Apomorphine is a non-selective dopamine agonist commonly used in veterinary medicine for the emergency management of toxicoses in dogs, through the induction of emesis. This review evaluates the currently reported effectiveness, adverse effects and recommendations of apomorphine as an emetic and considers alternatives. This is complemented by a retrospective study of 1126 dogs treated with apomorphine in emergency practice, to determine the efficacy of apomorphine in a clinical setting, and to provide identification of population characteristics, indications and outcomes of treated patients. The literature recognises apomorphine as a successful and consistent emetic for the retrieval of ingested harmful substances, with generally mild and self-limiting adverse effects. The retrospective study found that the most common reasons for presentation of the treated population were chocolate (26.8%), rodenticide (26.5%), foreign material (20.7%), and medication ingestion (11.6%). In this study, the two most influential factors on emetic and clinical outcome were the type of intoxicant and length of ingestion-to-presentation time. Breed size was an important determinant for the type of substance ingested, with variations noted between small, medium and large breed dogs. The most commonly estimated time from ingestion to presentation was 1–2 hours, with the substance, or parts thereof, successfully identified in the vomitus of 68.9% of cases. Apomorphine remains a valuable veterinary therapeutic for use in small animal emergency and critical care, providing a high rate of successful induction of emesis.
Title: Apomorphine hydrochloride: a clinical review with retrospective analysis of use in 1126 dogs treated in emergency practice
Description:
Apomorphine is a non-selective dopamine agonist commonly used in veterinary medicine for the emergency management of toxicoses in dogs, through the induction of emesis.
This review evaluates the currently reported effectiveness, adverse effects and recommendations of apomorphine as an emetic and considers alternatives.
This is complemented by a retrospective study of 1126 dogs treated with apomorphine in emergency practice, to determine the efficacy of apomorphine in a clinical setting, and to provide identification of population characteristics, indications and outcomes of treated patients.
The literature recognises apomorphine as a successful and consistent emetic for the retrieval of ingested harmful substances, with generally mild and self-limiting adverse effects.
The retrospective study found that the most common reasons for presentation of the treated population were chocolate (26.
8%), rodenticide (26.
5%), foreign material (20.
7%), and medication ingestion (11.
6%).
In this study, the two most influential factors on emetic and clinical outcome were the type of intoxicant and length of ingestion-to-presentation time.
Breed size was an important determinant for the type of substance ingested, with variations noted between small, medium and large breed dogs.
The most commonly estimated time from ingestion to presentation was 1–2 hours, with the substance, or parts thereof, successfully identified in the vomitus of 68.
9% of cases.
Apomorphine remains a valuable veterinary therapeutic for use in small animal emergency and critical care, providing a high rate of successful induction of emesis.
Related Results
A study of tolerance to apomorphine
A study of tolerance to apomorphine
The present study was designed to investigate tolerance to several pharmacological effects of apomorphine.Changes in blood pressure, heart rate, plasma noradrenaline levels, rectal...
Proceedings of the Qatar Paediatric Emergency Medicine 2026 Conference - Selected Abstracts
Proceedings of the Qatar Paediatric Emergency Medicine 2026 Conference - Selected Abstracts
Welcome to this issue of Panorama of Emergency Medicine (POEM) dedicated to the 10th Qatar Paediatric Emergency Medicine (Q-PEM) International Conference which was organised and ho...
Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study
Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study
AbstractWe investigated whether administration of the catechol‐O‐methyl transferase (COMT) inhibitor entacapone, at doses of 200 mg and 400 mg, alters the pharmacokinetics of apomo...
Development and validation of a rapid HPLC-UV method for simultaneous quantification of apomorphine and related impurities in drug products
Development and validation of a rapid HPLC-UV method for simultaneous quantification of apomorphine and related impurities in drug products
Abstract
Apomorphine, a potent dopamine agonist, plays a significant role in the management of advanced Parkinson's disease, and requires careful monitoring of th...
Use of Emetics and Anesthesia for Dietary Assessment of Weddell Seals
Use of Emetics and Anesthesia for Dietary Assessment of Weddell Seals
One female and 19 male Weddell seals, Leptonychotes weddellii, were injected with the emetic apomorphine hydrochloride. Fourteen of these were immobilised with combinations of keta...
Efficacy and safety of apomorphine in the treatment of Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
Efficacy and safety of apomorphine in the treatment of Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
Background:
Motor fluctuations and OFF episodes are common complications of long-term levodopa therapy in Parkinson’s disease (PD) and significantly impair qual...
The effects and D2 receptor-mediated mechanisms of dopaminergic system modulation in in-vivo and in-vitro experimental models of migraine
The effects and D2 receptor-mediated mechanisms of dopaminergic system modulation in in-vivo and in-vitro experimental models of migraine
The dopaminergic system is implicated in the pathophysiology of
migraine. However, the underlying mechanisms remain unclear. We explored
the effects and mechanisms of dopaminergic ...
Les faces cachées de l’apomorphine : leçons passées, contributions expérimentales actuelles et défis futurs
Les faces cachées de l’apomorphine : leçons passées, contributions expérimentales actuelles et défis futurs
Doyenne de la thérapeutique antiparkinsonienne, puissant outil pharmacologique au profil singulier, l’apomorphine est aujourd’hui indiquée comme thérapeutique de deuxième intention...

